Staff

Randy Rossi

Director, Sartorius Cell Culture Facility

201 Huck Life Sciences
University Park, PA 16802

Email rmr29@psu.edu
Phone 814-865-0777

Core Facilities

Sartorius Cell Culture Facility

Researchers have demonstrated proof-of-principle of a protein-based intranasal vaccine platform, called SpyCage, that could eventually help to prevent infection and transmission of respiratory viruses, like SARS-CoV-2. Image shows an illustration of the SpyCage vaccine platform, on right, decorated with a portion of the spike protein from SARS-CoV-2, next to an illustration of the virus. Credit: Dani Zemba / Penn State. Creative Commons

March 12, 2024

New nasal vaccine platform helps clear COVID-19 infections in an animal model

Researchers found that that the optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy is within 60 days of the onset of symptoms. IMAGE: VIKTORCAP, GETTY IMAGES

February 25, 2021

Study finds short window for donating convalescent plasma to COVID-19 patients

February 25, 2021

Study finds short window for donating convalescent plasma to COVID-19 patients

Legal Statements